Medicine passport

SANDOZ DEFERASIROX 125 mg

The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.

Active substance
Deferasirox
Strength
125 mg
Form
tablet for suspension
ATC code
V03AC03
Registered in
Canada · Sandoz Canada Incorporated
Prescription
Prescription only
DIN
02464454

Source: Drug Product Database · 2026-09-30

Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.

Listed in other countries

United States 11 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
Deferasirox125 mg · Tablet, for SuspensionPrescription onlyTeva Pharmaceuticals, Inc. (+9)0480-7011
Exjade125 mg · Tablet, for SuspensionPrescription onlyNovartis Pharmaceuticals Corporation0078-0468

Source: NDC Directory (US Food and Drug Administration) · 2026-09-13 · Source: US Food and Drug Administration, NDC Directory.

Spain 1 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
EXJADE125 mg · comprimido dispersablePrescription onlyNovartis Europharm Limited06356001

Source: CIMA — Centro de Información online de Medicamentos (Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)) · 2026-09-30 · Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA.

Same active substance, but no match for this strength and form

Countries covered: United States, Bulgaria, European Union, Spain, France, Netherlands, Canada, Switzerland. A country missing from the list may still sell this medicine: Mediclarum reads only these registers.

Register data as of 2026-09-30. Mediclarum stores nothing about you for this page. https://www.mediclarum.com/ca/en/medicines/sandoz-deferasirox-125-mg-tablet-for-suspension